By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Boehringer Ingelheim Corporation 

P.O. Box 368
900 Ridgebury Road
Ridgefield  Connecticut  06877-0368  U.S.A.
Phone: 203-798-99-88 Fax: 203-791-62-34


Company News
nanoPET Pharma Initiates R&D Partnership With Boehringer Ingelheim Corporation 12/1/2014 3:30:21 PM
Boehringer Ingelheim Corporation, Wellpoint, And HealthCore Announce First Project Under Multi-Year Research Collaboration 11/14/2014 10:58:36 AM
Boehringer Ingelheim Corporation Passes on Anthera, Inc.'s CV Antibody Option 11/13/2014 6:58:48 AM
Boehringer Ingelheim Corporation Release: FDA Study Of Medicare Patients Reaffirms Safety And Efficacy Profile Of Pradaxa® (Dabigatran Etexilate Mesylate) For NVAF 11/3/2014 7:22:35 AM
Hundreds Of New Jobs Coming To Virginia As UniTao Pharma Snaps Up Boehringer Ingelheim Corporation's Old Plant 10/31/2014 6:10:24 AM
Boehringer Ingelheim Corporation Introduces IDBS' E-Workbook Suite 10/28/2014 8:46:07 AM
Boehringer Ingelheim Corporation Presents Data For The Co-Administration Of Two Approved Products For COPD Patients 10/27/2014 8:32:24 AM
Boehringer Ingelheim Corporation Initiates Global Phase 3 Study Investigating Nintedanib In Patients With Colorectal Cancer 10/21/2014 7:17:00 AM
Boehringer Ingelheim Corporation Wins FDA Approval For Lung Disease Drug Ofev 10/15/2014 3:14:19 PM
Boehringer Ingelheim Corporation And Americares Partner To Expand Product Donations Program Globally 10/15/2014 10:49:17 AM